Pharmacoeconomics of allergic rhinitis drugs treatment in tertiary care hospital

Sanjeeva Kumar Goud Thandu; A. N. Vijay Kumar; Rahul Rajendra Kunkulol

doi:10.18203/2319-2003.ijbcp20194278

Authors

Sanjeeva Kumar Goud Thandu Department of Pharmacology, Pravara Institute of Medical Sciences, Loni (BK), Maharashtra, India
A. N. Vijay Kumar Department of Pharmacology, Vitthalrao Vikhe Patil Foundation’s Medical College, Ahmednagar Maharashtra, India
Rahul Rajendra Kunkulol Department of Pharmacology, Pravara Institute of Medical Sciences, Loni (BK), Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20194278

Keywords:

Allergic rhinitis, Cost analysis, Generic medicine

Abstract

Background: Allergic rhinitis also called hay fever; it is a very common in India. Harmless exposing substances cause an allergic reaction. Allergic rhinitis is of the two types, one is the seasonal occurred with the change of seasons, second is the perennial means any time during the year.

Methods: This was a cross-sectional study to determine the cost analysis allergic rhinitis drugs used in treatment of ENT OPD in a tertiary care teaching hospital, Kamothe, Navi Mumbai. The patients were interviewed; prescriptions were analyzed number of medicines prescribed.

Results: Incidence of polypharmacy two drugs per prescriptions were prescribed 140 and three drugs per prescriptions 60. In the total number of 200 prescriptions, the cost of 43 prescriptions were in between 251-300 Indian rupees and 18 prescriptions were 301-350 Indian rupees. Patient knowledge about the drug use in this study, out of 200 pts 37% of allergic rhinitis patients knew the correct dosage of the prescribed drugs while 63% were not aware.

Conclusions: Majority of the participants drugs were prescribed two to three drugs, per prescription cost was high because all the drugs prescribed by brand name and no drugs were prescribed by generic name. Improvement in knowledge about generic medicines is important factor to prefer generic medicine. Reduction in cost of drug will improve compliance.

Metrics

Metrics Loading ...

References

Gupta SK. Proposed Pharmacoeconomics Guidelines for India (PEG-I). IPSOR India Chapter; 2013:79-100.

Ahuja J, Gupta M, Gupta AK, Kohli K. Pharmacoeconomics. Natl Med J India 2004;17:80-3.

Trask L. Pharmacoeconomics: Principles, methods, and applications. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. eds. Pharmacotherapy: a pathophysiologic approach. 8ed. New York, NY: McGraw-Hill; 2011. Available from: http://accesspharmacy.mhmedical.com/ content.aspx? bookid=462&Sectionid=411007. [Last accessed on 13 Sep 2015].

Shubham Atal, Sarjana Ata, Bhagyashree Deshmankar, Syed A. Nawaz. Cost Analysis Of Commonly Used Drugs Under Price Control In India: Assessing The Effect Of Drug Price Control Order On Brand Price Variation .Int J Pharm Pharm Sci, Vol 8, Issue 4, 315-321

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160.

Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62 (84):1-41.

Babar ZU, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. “An evaluation of consumers knowledge, perceptions and attitudes regarding generic medicines in Auckland”. Pharma world science. 2010;32(4):440-8.

Thomas R, Vitry A. “Consumers perception of generic medicines in community pharmacies in Malaysia”. South Med Rev. 2009;2(2):20-3.

Andersson K, Bergstrom G, Petzold MG, Carlstern A. “Impact of a generic substitution reform on patients and society sexpenditure for pharmaceuticals”. Health Policy. 2007;81:376-84.

Shrank WH, Hoang T, Ettner SL, Glasssman PA, Nair K, DeLapp D, et al. The implications of choice; Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166:332-7.

DS Pearlman. Pathophysiology of the inflammatory response, Journal of Allergy and Clinical Immunology 2001; 104(4):132–137.

Sanjeeva Kumar Goud.Thandu, Rakesh Kumar, Vithal G. Patil, Darshana Dighe, Lalan H. N., Amarendra.singh. Drug Utilization Pattern in Upper Respiratory Tract Infections in ENT Outpatient Department of Tertiary Care Hospital. INDIAN JOURNAL OF APPLIED RESEARCH.2014 : 4 (5): 484-487.

13. Kozma CM, Schulz RM, Sclar DA, Kral KM, Mackowiak JI.A comparison of costs and efficacy of intranasal fluticasone and terfinaine tablets for seasonal allergic rhinitis. Clin Ther 1996;18:334-46.